Rapid shift to adalimumab biosimilars in Denmark contrasts with U.S. experienceMarch 31, 2020Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic ArthritisPediatrics
AAD-NPF releases first guidelines for nonbiologic treatments of psoriasisMarch 11, 2020Psoriatic Arthritis
HLA-B27 status predicts radiographic phenotype of axSpAMarch 2, 2020Ankylosing spondylitisSpondyloarthropathiesPsoriatic Arthritis
Meta-analysis highlights safety concerns with interleukin inhibitionMarch 2, 2020Rheumatoid ArthritisMixed TopicsPediatricsAnkylosing spondylitisPsoriatic ArthritisSpondyloarthropathies
New guideline offers recommendations for reproductive health in patients with rheumatic diseasesMarch 2, 2020Lupus & Connective Tissue DiseasesAnkylosing spondylitisRheumatoid ArthritisPsoriatic ArthritisSpondyloarthropathies
Specific markers detect psoriatic disease inflammation without elevated CRPFebruary 25, 2020Psoriatic Arthritis
Low-dose methotrexate trial pins down adverse event ratesFebruary 18, 2020Rheumatoid ArthritisPsoriatic Arthritis
Registry data reveal temporal relationship between psoriasis symptoms and PsA onsetJanuary 29, 2020Psoriatic Arthritis
In rheumatology, biosimilars are flatlining. Why?January 27, 2020Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
Apremilast more likely to succeed with moderate psoriatic arthritis activityJanuary 22, 2020Psoriatic Arthritis
